참고문헌 (60)

1. 1Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs . Nat Rev Drug Discov 2005 ; 4 : 307 –320. 15789122 

2. 2Rybak LP, Somani S. Ototoxicity Amelioration by protective agents. Ann N Y Acad Sci 1999 ; 884 : 143 –151. 10842591 

3. 3Deavall DG, Martin EA, Horner JM, Roberts R. Drug-induced oxidative stress and toxicity . J Toxicol 2012 ; 2012 : 645460 . 22919381 

4. 4Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies . Kidney Int 2008 ; 73 : 994 –1007. 18272962 

   상세보기

5. 5Kim HJ, Lee JH, Kim SJ, Oh GS, Moon HD, Kwon KB et al. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity . J Neurosci 2010 ; 30 : 3933 –3946. 20237264 

   상세보기

6. 6Jiang M, Yi X, Hsu S, Wang CY, Dong Z. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity . Am J Physiol Renal Physiol 2004 ; 287 : F1140 –F1147. 15315938 

   상세보기

7. 7So H, Kim H, Lee JH, Park C, Kim Y, Kim E et al. Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB . J Assoc Res Otolaryngol 2007 ; 8 : 338 –355. 17516123 

8. 8Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S et al. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53 . Am J Physiol Renal Physiol 2011 ; 301 : F427 –F435. 21593185 

   상세보기

9. 9Oh GS, Kim HJ, Choi JH, Shen A, Choe SK, Karna A et al. Pharmacological activation of NQO1 increases NAD levels and attenuates cisplatin-mediated acute kidney injury in mice . Kidney Int 2014 ; 85 : 547 –560. 24025646 

10. 10Oka S, Hsu CP, Sadoshima J. Regulation of cell survival and death by pyridine nucleotides . Circ Res 2012 ; 111 : 611 –627. 22904041 

    상세보기

11. 11Abdellatif M. Sirtuins and pyridine nucleotides . Circ Res 2012 ; 111 : 642 –656. 22904043 

    상세보기

12. 12Imai S, Kiess W. Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes . Front Biosci (Landmark Ed) 2009 ; 14 : 2983 –2995. 19273250 

13. 13Belenky P, Bogan KL, Brenner C. NAD+ metabolism in health and disease . Trends Biochem Sci 2007 ; 32 : 12 –19. 17161604 

    상세보기

14. 14Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, Sauve AA et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt . Dev Cell 2008 ; 14 : 661 –673. 18477450 

    상세보기

15. 15Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis . EMBO J 2007 ; 26 : 3169 –3179. 17581637 

    상세보기

16. 16Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function . Biochem J 2007 ; 404 : 1 –13. 17447894 

    상세보기

17. 17Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W et al. Mammalian SIRT1 represses forkhead transcription factors . Cell 2004 ; 116 : 551 –563. 14980222 

    상세보기

18. 18Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase . Cell 2001 ; 107 : 149 –159. 11672523 

    상세보기

19. 19Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase . EMBO J 2004 ; 23 : 2369 –2380. 15152190 

    상세보기

20. 20Pillai JB, Isbatan A, Imai S, Gupta MP. Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity . J Biol Chem 2005 ; 280 : 43121 –43130. 16207712 

21. 21Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors . Pharmacol Rev 2002 ; 54 : 375 –429. 12223530 

    상세보기

22. 22Mukhopadhyay P, Horvath B, Kechrid M, Tanchian G, Rajesh M, Naura AS et al. Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury . Free Radic Biol Med 2011 ; 51 : 1774 –1788. 21884784 

    상세보기

23. 23Shino Y, Itoh Y, Kubota T, Yano T, Sendo T, Oishi R. Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells . Free Radic Biol Med 2003 ; 35 : 966 –977. 14556861 

    상세보기

24. 24Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms . Chem Biol Interact 2000 ; 129 : 77 –97. 11154736 

    상세보기

25. 25Gaikwad A, Long DJII, Stringer JL, Jaiswal AK. In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue . J Biol Chem 2001 ; 276 : 22559 –22564. 11309386 

    상세보기

26. 26Pazdro R, Burgess JR. The antioxidant 3H-1,2-dithiole-3-thione potentiates advanced glycation end-product-induced oxidative stress in SH-SY5Y cells . Exp Diabetes Res 2012 ; 2012 : 137607 . 22675339 

27. 27Jones CIIII, Zhu H, Martin SF, Han Z, Li Y, Alevriadou BR. Regulation of antioxidants and phase 2 enzymes by shear-induced reactive oxygen species in endothelial cells . Ann Biomed Eng 2007 ; 35 : 683 –693. 17340195 

    상세보기

28. 28Moscovitz O, Tsvetkov P, Hazan N, Michaelevski I, Keisar H, Ben-Nissan G et al. A mutually inhibitory feedback loop between the 20S proteasome and its regulator . NQO1. Mol Cell 2012 ; 47 : 76 –86. 22793692 

29. 29Haefeli RH, Erb M, Gemperli AC, Robay D, Courdier Fruh I, Anklin C et al. NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels . PLoS One 2011 ; 6 : e17963 . 21483849 

30. 30Huang X, Dong Y, Bey EA, Kilgore JA, Bair JS, Li LS et al. An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis . Cancer Res 2012 ; 72 : 3038 –3047. 22532167 

    상세보기

31. 31Pardee AB, Li YZ, Li CJ. Cancer therapy with beta-lapachone . Curr Cancer Drug Targets 2002 ; 2 : 227 –242. 12188909 

    상세보기

32. 32Li LS, Bey EA, Dong Y, Meng J, Patra B, Yan J et al. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of beta-lapachone for pancreatic cancer therapy . Clin Cancer Res 2011 ; 17 : 275 –285. 21224367 

33. 33Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, Church DR et al. Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response . Cancer Res 1995 ; 55 : 3706 –3711. 7641180 

    상세보기

34. 34Hwang JH, Kim DW, Jo EJ, Kim YK, Jo YS, Park JH et al. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice . Diabetes 2009 ; 58 : 965 –974. 19136651 

    상세보기

35. 35Kim SY, Jeoung NH, Oh CJ, Choi YK, Lee HJ, Kim HJ et al. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation . Circ Res 2009 ; 104 : 842 –850. 19229058 

    상세보기

36. 36Kim YH, Hwang JH, Noh JR, Gang GT, Kim do H, Son HY et al. Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity . Cardiovasc Res 2011 ; 91 : 519 –527. 21502369 

    상세보기

37. 37Kim YH, Hwang JH, Noh JR, Gang GT, Tadi S, Yim YH et al. Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase. Free . Radic Biol Med 2012 ; 52 : 880 –888. 

38. 38Lee JS, Park AH, Lee SH, Lee SH, Kim JH, Yang SJ et al. Beta-lapachone, a modulator of NAD metabolism, prevents health declines in aged mice . PLoS One 2012 ; 7 : e47122 . 23071729 

    상세보기

39. 39David KK, Andrabi SA, Dawson TM, Dawson VL. Parthanatos, a messenger of death . Front Biosci (Landmark Ed) 2009 ; 14 : 1116 –1128. 19273119 

40. 40Hermeking H. The miR-34 family in cancer and apoptosis . Cell Death Differ 2010 ; 17 : 193 –199. 19461653 

    상세보기

41. 41Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis . Proc Natl Acad Sci USA 2008 ; 105 : 13421 –13426. 18755897 

    상세보기

42. 42de Jongh FE, van Veen RN, Veltman SJ, de Wit R, van der Burg ME, van den Bent MJ et al. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients . Br J Cancer 2003 ; 88 : 1199 –1206. 12698184 

    상세보기

43. 43Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA et al. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer . Br J Cancer 1998 ; 77 : 1355 –1362. 9579846 

    상세보기

44. 44Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development . J Clin Oncol 2005 ; 23 : 8588 –8596. 16314621 

    상세보기

45. 45Krishnakumar R, Kraus WL. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets . Mol Cell 2010 ; 39 : 8 –24. 20603072 

46. 46Goodwin PM, Lewis PJ, Davies MI, Skidmore CJ, Shall S. The effect of gamma radiation and neocarzinostatin on NAD and ATP levels in mouse leukaemia cells . Biochim Biophys Acta 1978 ; 543 : 576 –582. 214144 

47. 47Skidmore CJ, Davies MI, Goodwin PM, Halldorsson H, Lewis PJ, Shall S et al. The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma-radiation and N-methyl-N-nitrosourea . Eur J Biochem 1979 ; 101 : 135 –142. 228934 

    상세보기

48. 48Canto C, Auwerx J. NAD+ as a signaling molecule modulating metabolism . Cold Spring Harb Symp Quant Biol 2012 ; 76 : 291 –298. 

49. 49Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H et al. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function . J Biol Chem 2010 ; 285 : 13045 –13056. 20139070 

    상세보기

50. 50Revollo JR, Li X. The ways and means that fine tune Sirt1 activity . Trends Biochem Sci 2013 ; 38 : 160 –167. 23394938 

    상세보기

51. 51Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E et al. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury . J Am Soc Nephrol 2009 ; 20 : 1754 –1764. 19470675 

    상세보기

52. 52Kruse JP, Gu W. Modes of p53 regulation . Cell 2009 ; 137 : 609 –622. 19450511 

    상세보기

53. 53Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acetylation is indispensable for p53 activation . Cell 2008 ; 133 : 612 –626. 18485870 

    상세보기

54. 54Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A et al. Negative control of p53 by Sir2alpha promotes cell survival under stress . Cell 2001 ; 107 : 137 –148. 11672522 

55. 55Brooks CL, Gu W. The impact of acetylation and deacetylation on the p53 pathway . Protein Cell 2011 ; 2 : 456 –462. 21748595 

    상세보기

56. 56Neumann M, Naumann M. Beyond IkappaBs: alternative regulation of NF-kappaB activity . FASEB J 2007 ; 21 : 2642 –2654. 17431096 

    상세보기

57. 57Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes . Mol Cell Biol 2009 ; 29 : 1363 –1374. 19103747 

    상세보기

58. 58Chen LF, Greene WC. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation . J Mol Med (Berl) 2003 ; 81 : 549 –557. 12920522 

59. 59Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK et al. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-kappaB p65 subunit and cytotoxicity in renal proximal tubule cells . Biochem Biophys Res Commun 2012 ; 419 : 206 –210. 22330808 

60. 60Gang GT, Kim YH, Noh JR, Kim KS, Jung JY, Shong M et al. Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity . Toxicol Lett 2013 ; 221 : 165 –175. 23831944 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.